Advisor Group Holdings, Inc. Comera Life Sciences Holdings, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.29 - $0.68 $4,393 - $10,302	-15,150 Reduced 80.8%	3,600 $1,000
Q2 2023 Aug 10, 2023	SELL	$0.4 - $0.89 $64 - $142	-160 Reduced 0.85%	18,750 $9,000
Q1 2023 May 12, 2023	SELL	$0.84 - $1.9 $840 - $1,900	-1,000 Reduced 5.02%	18,910 $17,000
Q4 2022 Feb 10, 2023	BUY	$1.2 - $1.93 $1,980 - $3,184	1,650 Added 9.04%	19,910 $24,000
Q3 2022 Nov 14, 2022	BUY	$0.09 - $4.01 $175 - $7,819	1,950 Added 11.96%	18,260 $29,000
Q2 2022 Aug 10, 2022	BUY	$1.17 - $14.25 $19,082 - $232,417	16,310 New	16,310 $43,000

Ticker CMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,087,200
Market Cap $382K
Description
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.